|
|
|
Corporate Profile: Ascenta Therapeutics
| Summary: |
Ascenta Therapeutics is focused on research and development of orally administered small molecule drugs that restore the natural potential for cancer cells to undergo apoptosis.
|
| Address (HQ): |
101 Lindenwood Drive
Suite 405
Malvern, PA 19355 |
| Phone #'s (HQ): |
| Main |
(610) 408-0301 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(610) 725-1515 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
